🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our recent research on ANGPT2 regulation of T-cell exclusion in melanoma, which has been featured as the cover article in Cancer Research, effective today. Congratulations to my team! aacrjournals.org/cancerres/arti…

#ICYMI— ANGPT2 limits the efficacy of #immunotherapy by inducing vascular destabilization at the tumor periphery to promote #Tcell exclusion in #melanoma, & targeting ANGPT2/TIE2 signaling potentiates the response to immune checkpoint blockade. bit.ly/3XFr5uL Minah Kim

Very exciting to share our recent work on angiopoietin-2 as a regulator of liver metastases in PanNETs. Thanks to all the collaborators and advisors who contributed to this project. Already looking forward to our next journey. Journal of Clinical Investigation pubmed.ncbi.nlm.nih.gov/37843277/

MRF Breakthrough Consortium (MRFBC) Translational Award Recipient Minah Kim, MD Minah Kim Columbia University presented her work titled, “Identification of Angiopoietin-2/ Tie Signaling Molecules as a Predictive Biomarker for Checkpoint Inhibitor Resistance in Melanoma” at the MRFBC

Columbia University researcher Minah Kim presents "Vascular regulation of liver metastasis in PanNET" at #2023NETRFResearchSymposium #CancerResearch #LetsTalkAboutNETs

Grateful for an insightful visit to the William Harvey Research Institute in London. Special thanks to Sussan for her warm hospitality and inviting me to the seminar! Sussan Nourshargh Lab

Congratulations to Minah Kim, PhD, recipient of the 2025 Cancer Research Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators. Learn more: brnw.ch/21wSfdo #AACR25 Minah Kim Columbia Pathology Columbia Medicine AACR